A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2004
11/04/2004	US20040219201 Tempamine compositions and methods of use
11/04/2004	US20040219148 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients
11/04/2004	US20040219144 administering an anti-human NGF monoclonal antibody capable of binding hNGF with an affinity in the nanomolar range, and inhibiting the binding of hNGF to human TrkA (hTrkA) in vivo, wherein said antibody has no significant adverse effect on the immune system
11/04/2004	CA2809164A1 Postnatal stem cells and uses thereof
11/04/2004	CA2522960A1 Therapeutic combination of a cox-2 inhibitor and an aromatase inhibitor
11/04/2004	CA2522718A1 A novel method of modulating bone-related activity
11/04/2004	CA2522682A1 Indazole derivatives as jnk inhibitors
11/04/2004	CA2520655A1 Compositions for mucosal and oral administration comprising hcg fragments
11/03/2004	EP1473295A1 Fused bicyclic pyrimidine derivatives
11/03/2004	EP1473040A1 Use of human parathyroid hormone
11/03/2004	EP1472540A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
11/03/2004	EP1472377A2 Genetic polymorphisms in the preprotachykinin gene
11/03/2004	EP1472364A2 Truncated aggrecanase molecules
11/03/2004	EP1472353A2 Group b streptococcus antigen
11/03/2004	EP1472351A2 Amino acid sequences capable of facilitating penetration across a biological barrier
11/03/2004	EP1472341A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/03/2004	EP1472282A2 Use of calmodulin to promote bone regeneration
11/03/2004	EP1472279A1 A method for inhibiting "melanoma inhibitory activity" mia
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1472269A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2004	EP1472267A2 Rna interference mediated inhibition of protein tyrosine phosphatase type iva (prl3) gene expression using short interfering nucleic acid (sina)
11/03/2004	EP1472257A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
11/03/2004	EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004	EP1472243A1 Piperidine derivatives and their use as antagonists of tachykinins
11/03/2004	EP1472241A1 Cytoprotective benzofuran derivatives
11/03/2004	EP1472237A1 Catechol bioisosteres
11/03/2004	EP1472230A2 Ansamycins having improved pharmacological and biological properties
11/03/2004	EP1472224A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
11/03/2004	EP1472209A2 Lipoxin a4 analogs
11/03/2004	EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004	EP1471928A1 Hiv inhibiting proteins
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471926A2 Compositions and methods for the therapeutic use of an atonal-associated sequence
11/03/2004	EP1471916A2 Treatment of rheumatoid arthritis using imatinie
11/03/2004	EP1471907A2 Use of tyrosine kinase inhibitors for treating autoimmune diseases
11/03/2004	EP1471886A1 Method for increasing the water-solubility of lipophilic, active substances, production of highly concentrated aqueous compositions of said active substances, corresponding products and their use
11/03/2004	EP1435906A4 Method for producing biologically active products
11/03/2004	EP1404315B1 Synergistic compositions of n-acylhomoserine lactones and 4-quinolones
11/03/2004	EP1339716B1 lactam-substituted pyrazolopyridine derivatives
11/03/2004	EP1235814B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
11/03/2004	EP1169338B1 Low-molecular inhibitors of complement proteases
11/03/2004	EP1105371B1 Novel aryl sulphonamide amino acid esters and analogues
11/03/2004	EP0729325B1 Osteogenic product and use
11/03/2004	CN1543459A Quinoline derivatives and quinazoline derivatives having azolyl group
11/03/2004	CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/03/2004	CN1543362A Medical products comprising a haemocompatible coating, production and use thereof
11/03/2004	CN1543357A 5-CNAC as oral delivery agent for parathyroid hormone fragments
11/03/2004	CN1543353A Composition for treatment of articular cartilage damage
11/03/2004	CN1542019A Anti human non-Hodgkin's lymphoma chimeric antibody and its derivative and application
11/03/2004	CN1542006A Salt of phenylacetyl-(N-methyl)leucine-aspartic acid- phenylalanine-(N-methyl)piperazine
11/03/2004	CN1542002A Inhibitors of metalloproteinase, pharmaceutical compositions containing them, their pharmaceutical application and methods and intermediate compounds for their preparation
11/03/2004	CN1541704A Osteoprosis treating medicament and osteoclast creating inhibitor
11/03/2004	CN1541703A Externally applied preparation for removing dampness and relieving osteodynia
11/03/2004	CN1541700A Method for extracting active arthritis resisting element from Capparis fruit
11/03/2004	CN1541694A Reumatic arthritis treating medicine
11/03/2004	CN1541685A Traditional Chinese medicine composition for treating rheumatic arthritis and atrophic arthritis
11/03/2004	CN1541668A Osteopathy treating ointment
11/03/2004	CN1541666A Chinese traditional medicine composition for treating bedsore and acute soft tissue injury
11/03/2004	CN1174097C Macrophage activating factors derived from cloned vitamin D binding protein
11/03/2004	CN1173992C Hybrid peptide with vascularization inhibiting activity
11/03/2004	CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
11/03/2004	CN1173973C Benzocarbazole and indenoindole derived estrogenic agents
11/03/2004	CN1173944C New vitamin-D derivatives with carbon ring or heterocyclic substitutents at C-25, process for the preparation, intermediate products and their use for producing medicaments
11/03/2004	CN1173727C Chinese medicine liquor for clearing and activating main and collateral channels, and its preparation method
11/03/2004	CN1173722C Chinese medicine for treating femur head necrosis and its preparing process
11/03/2004	CN1173721C External-use ointment
11/03/2004	CN1173718C Medicine for curing rheumatism arising from immune diease lupus erythematosus
11/03/2004	CN1173704C Use of ibandronate for promoting osseocicatrization of endoprosthesis
11/02/2004	US6812253 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
11/02/2004	US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004	US6812244 Naphthyl compounds, intermediates, compositions, and methods of use
11/02/2004	US6812236 Compounds useful in therapy
11/02/2004	US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression
11/02/2004	US6812223 Crystalline glucosamine sulfate metal salts and processes for preparing the same
11/02/2004	US6812220 Pharmaceutical compositions and methods relating to fucans
11/02/2004	US6812215 Compositions for the treatment of inflammatory joint diseases and osteoporosis
11/02/2004	US6812214 Use of harpagid-related compounds for prevention and treatment of osteoporosis, arthritis and ruptured disc and pharmaceutical composition containing the same
11/02/2004	US6812203 Treatment of cd40 and/or nf-kb related diseases, antiinflammatory, antitumor
11/02/2004	US6812034 Diagnosing calcification of arteries; obtain blood sample, screen for the presence of fetuin-mineral complex in blood, amplified concentration of fetuin complex indicates calcification of arteries and other soft tissues
11/02/2004	US6812021 Isolated from streptococcus; for preparation of therapeutics (vaccines) to immunize against microbial infection; urinary tract infections; drug screening
11/02/2004	US6811999 Method for determining calciotropic activity of a preparation of Padina pavonica algae
11/02/2004	US6811779 Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
11/02/2004	US6811777 Compositions and minimally invasive methods for treating incomplete connective tissue repair
11/02/2004	CA2296313C 2-aminopyridines containing fused ring substituents as nos inhibitors
11/02/2004	CA2111100C Interleukin-1 beta protease and interleukin-1 beta protease inhibitors
10/2004
10/28/2004	WO2004092215A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
10/28/2004	WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004	WO2004092169A1 Spiropiperidine compound and medicinal use thereof
10/28/2004	WO2004092147A1 M-stage kinesin inhibitor
10/28/2004	WO2004092144A2 Quinazoline compounds useful as p38 kinase inhibitors
10/28/2004	WO2004092136A1 Nitrogenous heterocyclic compound and use thereof
10/28/2004	WO2004092134A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004	WO2004092132A1 [b]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004	WO2004092118A2 2-propylidene-19-nor-vitamin d compounds
10/28/2004	WO2004091642A1 Preventive or remedy for arthritis
10/28/2004	WO2004091628A1 Receptor antagonist
10/28/2004	WO2004091625A1 (6-(phenoxy)-pyrido`3,4-d! pyrimidin-2-yl)-amine derivatives as p38 kinase inhibitors for the treatment of inflammatoryy conditions such as rheumatois artritis
10/28/2004	WO2004091591A2 Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof
10/28/2004	WO2004075828A3 Pharmaceutical composition of alendronic acid, salts or esters thereof, and a process for its preparation
10/28/2004	WO2004064716A3 Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders

1 ... 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 ... 820